Literature DB >> 31358521

Neural Control of Inflammation: Bioelectronic Medicine in Treatment of Chronic Inflammatory Disease.

Michael Eberhardson1, Laura Tarnawski1, Monica Centa1, Peder S Olofsson1,2.   

Abstract

Inflammation is important for antimicrobial defense and for tissue repair after trauma. The inflammatory response and its resolution are both active processes that must be tightly regulated to maintain homeostasis. Excessive inflammation and nonresolving inflammation cause tissue damage and chronic disease, including autoinflammatory and cardiovascular diseases. An improved understanding of the cellular and molecular mechanisms that regulate inflammation has supported development of novel therapies for several inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. Many of the specific anticytokine therapies carry a risk for excessive immunosuppression and serious side effects. The discovery of the inflammatory reflex and the increasingly detailed understanding of the molecular interactions between homeostatic neural reflexes and the immune system have laid the foundation for bioelectronic medicine in the field of inflammatory diseases. Neural interfaces and nerve stimulators are now being tested in human clinical trials and may, as the technology develops further, have advantages over conventional drugs in terms of better compliance, continuously adaptable control of dosing, better monitoring, and reduced risks for unwanted side effects. Here, we review the current mechanistic understanding of common autoinflammatory conditions, consider available therapies, and discuss the potential use of increasingly capable devices in the treatment of inflammatory disease.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31358521      PMCID: PMC7050580          DOI: 10.1101/cshperspect.a034181

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  121 in total

1.  The fiber composition of the abdominal vagus of the rat.

Authors:  J C Prechtl; T L Powley
Journal:  Anat Embryol (Berl)       Date:  1990

2.  Choline acetyltransferase-expressing T cells are required to control chronic viral infection.

Authors:  Maureen A Cox; Gordon S Duncan; Gloria H Y Lin; Benjamin E Steinberg; Lisa X Yu; Dirk Brenner; Luke N Buckler; Andrew J Elia; Andrew C Wakeham; Brian Nieman; Carmen Dominguez-Brauer; Alisha R Elford; Kyle T Gill; Shawn P Kubli; Jillian Haight; Thorsten Berger; Pamela S Ohashi; Kevin J Tracey; Peder S Olofsson; Tak W Mak
Journal:  Science       Date:  2019-02-08       Impact factor: 47.728

3.  Bioelectronic medicine: technology targeting molecular mechanisms for therapy.

Authors:  P S Olofsson; K J Tracey
Journal:  J Intern Med       Date:  2017-07       Impact factor: 8.989

Review 4.  The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Semin Immunol       Date:  2015-04-07       Impact factor: 11.130

Review 5.  Nonresolving inflammation.

Authors:  Carl Nathan; Aihao Ding
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 6.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

Review 7.  Overview of Immunodeficiency Disorders.

Authors:  Nikita Raje; Chitra Dinakar
Journal:  Immunol Allergy Clin North Am       Date:  2015-08-25       Impact factor: 3.479

8.  Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution.

Authors:  Jesmond Dalli; Romain A Colas; Hildur Arnardottir; Charles N Serhan
Journal:  Immunity       Date:  2017-01-05       Impact factor: 31.745

Review 9.  Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells.

Authors:  S Alivernini; B Tolusso; G Ferraccioli; E Gremese; M Kurowska-Stolarska; I B McInnes
Journal:  Clin Exp Immunol       Date:  2018-02-02       Impact factor: 4.330

10.  Pain and infection: pathogen detection by nociceptors.

Authors:  Isaac M Chiu; Felipe A Pinho-Ribeiro; Clifford J Woolf
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

View more
  5 in total

1.  Vagus nerve stimulation promotes resolution of inflammation by a mechanism that involves Alox15 and requires the α7nAChR subunit.

Authors:  April S Caravaca; Alessandro L Gallina; Laura Tarnawski; Vladimir S Shavva; Romain A Colas; Jesmond Dalli; Stephen G Malin; Henrik Hult; Hildur Arnardottir; Peder S Olofsson
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-27       Impact factor: 12.779

2.  Vagus Nerve Stimulation Reduces Indomethacin-Induced Small Bowel Inflammation.

Authors:  April S Caravaca; Yaakov A Levine; Anna Drake; Michael Eberhardson; Peder S Olofsson
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

3.  Research-Based Product Innovation to Address Critical Unmet Needs of Patients with Inflammatory Bowel Diseases.

Authors:  Gerard Honig; Paul B Larkin; Caren Heller; Andrés Hurtado-Lorenzo
Journal:  Inflamm Bowel Dis       Date:  2021-11-15       Impact factor: 5.325

Review 4.  Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patients.

Authors:  Christopher J Czura; Marom Bikson; Leigh Charvet; Jiande D Z Chen; Manfred Franke; Marat Fudim; Eric Grigsby; Sam Hamner; Jared M Huston; Navid Khodaparast; Elliot Krames; Bruce J Simon; Peter Staats; Kristl Vonck
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

Review 5.  Auricular neural stimulation as a new non-invasive treatment for opioid detoxification.

Authors:  Imran S Qureshi; Timir Datta-Chaudhuri; Kevin J Tracey; Valentin A Pavlov; Andrew C H Chen
Journal:  Bioelectron Med       Date:  2020-03-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.